These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32655239)

  • 1. The Current Hepatic Encephalopathy Pipeline.
    Ryu AJ; Rahimi RS; Leise MD
    J Clin Exp Hepatol; 2020; 10(4):377-385. PubMed ID: 32655239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Drugs for the Management of Hepatic Encephalopathy: Still a Long Journey to Travel.
    Rajpurohit S; Musunuri B; Shailesh ; Basthi Mohan P; Shetty S
    J Clin Exp Hepatol; 2022; 12(4):1200-1214. PubMed ID: 35814520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial.
    Rahimi RS; Singal AG; Cuthbert JA; Rockey DC
    JAMA Intern Med; 2014 Nov; 174(11):1727-33. PubMed ID: 25243839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation in hepatic encephalopathy: a systematic review.
    Madsen M; Kimer N; Bendtsen F; Petersen AM
    Scand J Gastroenterol; 2021 May; 56(5):560-569. PubMed ID: 33840331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
    Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined PEG3350 Plus Lactulose Results in Early Resolution of Hepatic Encephalopathy and Improved 28-Day Survival in Acute-on-Chronic Liver Failure.
    Ahmed S; Premkumar M; Dhiman RK; Kulkarni AV; Imran R; Duseja A; Kaur P; Taneja S; Singh V; Mishra S; Roy A; Mehtani R
    J Clin Gastroenterol; 2022 Jan; 56(1):e11-e19. PubMed ID: 33060437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial.
    Naderian M; Akbari H; Saeedi M; Sohrabpour AA
    Middle East J Dig Dis; 2017 Jan; 9(1):12-19. PubMed ID: 28316761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethylene glycol versus lactulose in the treatment of hepatic encephalopathy: a systematic review and meta-analysis.
    Hoilat GJ; Ayas MF; Hoilat JN; Abu-Zaid A; Durer C; Durer S; Adhami T; John S
    BMJ Open Gastroenterol; 2021 May; 8(1):. PubMed ID: 34006606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active Clinical Trials in Hepatic Encephalopathy: Something Old, Something New and Something Borrowed.
    Balzano T
    Neurochem Res; 2023 Aug; 48(8):2309-2319. PubMed ID: 36977964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Therapies in Hepatic Encephalopathy.
    Alimirah M; Sadiq O; Gordon SC
    Clin Liver Dis; 2020 May; 24(2):303-315. PubMed ID: 32245535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy.
    Bongaerts G; Severijnen R; Timmerman H
    Med Hypotheses; 2005; 64(1):64-8. PubMed ID: 15533613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome therapeutics for hepatic encephalopathy.
    Bloom PP; Tapper EB; Young VB; Lok AS
    J Hepatol; 2021 Dec; 75(6):1452-1464. PubMed ID: 34453966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.
    Alsahhar JS; Rahimi RS
    Curr Opin Gastroenterol; 2019 May; 35(3):145-154. PubMed ID: 30893082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment.
    Hassouneh R; Bajaj JS
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33477417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Link between Gut Microbiota and Hepatic Encephalopathy.
    Won SM; Oh KK; Gupta H; Ganesan R; Sharma SP; Jeong JJ; Yoon SJ; Jeong MK; Min BH; Hyun JY; Park HJ; Eom JA; Lee SB; Cha MG; Kwon GH; Choi MR; Kim DJ; Suk KT
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonpharmacologic Management of Hepatic Encephalopathy: An Update.
    Weir V; Reddy KR
    Clin Liver Dis; 2020 May; 24(2):243-261. PubMed ID: 32245531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota.
    Wang MW; Ma WJ; Wang Y; Ma XH; Xue YF; Guan J; Chen X
    Front Microbiol; 2023; 14():1091167. PubMed ID: 37032856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy.
    Chen Z; Ruan J; Li D; Wang M; Han Z; Qiu W; Wu G
    Front Cell Infect Microbiol; 2020; 10():595759. PubMed ID: 33553004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics for patients with hepatic encephalopathy.
    McGee RG; Bakens A; Wiley K; Riordan SM; Webster AC
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008716. PubMed ID: 22071855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetyl-L-carnitine for patients with hepatic encephalopathy.
    Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011451. PubMed ID: 30610762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.